These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 29433130)
1. [The elimination of measles and rubella in Italy]. Adamo G; Sturabotti G; De Soccio P; Prencipe GP; Sciarra I; Baccolini V; Massimi A; Marzuillo C; Iannazzo S; Villari P Ig Sanita Pubbl; 2017; 73(5):429-442. PubMed ID: 29433130 [TBL] [Abstract][Full Text] [Related]
2. The end of measles and congenital rubella: an achievable dream? Adamo G; Sturabotti G; D'Andrea E; Baccolini V; Romano F; Iannazzo S; Marzuillo C; Villari P Ann Ig; 2017; 29(1):1-26. PubMed ID: 28067934 [TBL] [Abstract][Full Text] [Related]
3. Towards elimination of measles and rubella in Italy: Progress and challenges. Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530 [TBL] [Abstract][Full Text] [Related]
4. Progress in Italy in control and elimination of measles and congenital rubella. Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425 [TBL] [Abstract][Full Text] [Related]
5. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey. Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393 [TBL] [Abstract][Full Text] [Related]
6. Surveillance and vaccination coverage of measles and rubella in Northern Italy. Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537 [TBL] [Abstract][Full Text] [Related]
7. Progress in the elimination of measles and congenital rubella in Central Italy. Bechini A; Levi M; Boccalini S; Tiscione E; Panatto D; Amicizia D; Bonanni P Hum Vaccin Immunother; 2013 Mar; 9(3):649-56. PubMed ID: 23292174 [TBL] [Abstract][Full Text] [Related]
8. The State of Measles and Rubella in the WHO European region. Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789 [TBL] [Abstract][Full Text] [Related]
9. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases. Thompson KM; Badizadegan ND Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947 [TBL] [Abstract][Full Text] [Related]
10. Progress in measles and rubella elimination in Iran. Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452 [TBL] [Abstract][Full Text] [Related]
11. Eliminating measles and rubella in Europe. Allerberger F Clin Microbiol Infect; 2017 Aug; 23(8):502-503. PubMed ID: 28412385 [No Abstract] [Full Text] [Related]
12. Is the current prevention strategy based on vaccination coverage and epidemiological surveillance sufficient to achieve measles and rubella elimination in Europe? Plans-Rubio P Expert Rev Anti Infect Ther; 2014 Jul; 12(7):723-6. PubMed ID: 24807016 [TBL] [Abstract][Full Text] [Related]
13. [Activities to catch up and Vaccinate the Susceptible Population in Valencian Community, Spain]. Martín-Ivorra R; Alguacil-Ramos AM; Lluch-Rodrigo JA; Pastor-Villalba E; Portero-Alonso A Rev Esp Salud Publica; 2015; 89(4):419-26. PubMed ID: 26580797 [TBL] [Abstract][Full Text] [Related]
14. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination]. Limia Sánchez A; Molina Olivas M Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791 [TBL] [Abstract][Full Text] [Related]
16. Research priorities for global measles and rubella control and eradication. Goodson JL; Chu SY; Rota PA; Moss WJ; Featherstone DA; Vijayaraghavan M; Thompson KM; Martin R; Reef S; Strebel PM Vaccine; 2012 Jul; 30(32):4709-16. PubMed ID: 22549089 [TBL] [Abstract][Full Text] [Related]
17. [Elimination of measles and rubella in Germany: Progress and hindrances]. Pfaff G Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1222-4. PubMed ID: 23990082 [No Abstract] [Full Text] [Related]
18. [Progress in the elimination of measles and rubella in the WHO European Region]. Muscat M; Jankovic D; Goel A; Butler R; Pfeifer D Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1225-30. PubMed ID: 23990083 [TBL] [Abstract][Full Text] [Related]
19. Progress Toward Measles Elimination - European Region, 2009-2018. Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675 [TBL] [Abstract][Full Text] [Related]
20. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]